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ABSTRACT This report describes the cytoskeleton nature of a 60,000-mol-wt protein, P60,
previously shown to undergo Cal' influx-induced phosphorylation concomitant with insulin
release in hamster insulinoma cells. Four lines of evidence suggest that P60 is an intermediate
filament protein of the keratin class. (a) As previously described (Schubart, U.K., 1982, J. Biol.
Chem. 257:12231-12238), Triton X-100-insoluble cytoskeletons are enriched for P6o; (b) these
cytoskeletons contain 7-11-nm filaments as determined by negative staining; (c) immunoblot
analysis revealed that all proteins detected in the insulinoma cell cytoskeletons are recognized
by a monoclonal antibody that interacts with a common determinant in all intermediate
filament proteins; and (d) P60 was shown, by its identical migration on two-dimensional
electrophoresis and by its immunologic relatedness, to be analogous to a known keratin
present in HeLa cells. An antibody specific for P6o, as judged by immunoblotting, was
developed in a rabbit. In indirect immunofluorescence studies on insulinoma cells, this anti-
P60 antibody produced a filamentous staining pattern. The antibody also permitted the
identification of P60 in normal pancreatic islets as determined both by immunoblotting of
hamster islet proteins resolved by two-dimensional electrophoresis and by indirect immuno-
fluorescence microscopy on cryostat sections of hamster pancreas. In addition, the antibody
recognized an antigen in the epithelial layer of pancreatic exocrine ducts, as determined by
indirect immunofluorescence. The data have implications for the embryonic origin of pan-
creatic islets. Together with the phosphorylation data, these findings suggest that this islet cell
cytokeratin may be involved in the regulation of insulin release.
The critical role of Ca" in insulin release is well established
(for review, see reference 1). To gain insights into the mech-
anism by which Cal' activates the secretory process, we are
exploring the molecular events that occur in pancreatic beta-
cellsduring Cal'-mediatedinsulin release. These studies have
utilized cells isolated from a transplantable hamster insuli-
noma, which release insulin in response to depolarization-
induced Ca" influx (2). The current hypothesis assumes that
protein phosphorylation may be involved in Ca"-mediated
insulin release (3). In this regard, we have demonstrated that
these insulinoma cells contain a Ca2'-activated protein kinase
activity that also requires calmodulin (4). In addition, we have
shown that depolarization-induced CaZ+ influx stimulates
phosphorylation ofa 60,000-mol-wtprotein, P60, concomitant
with insulin release in intact insulinoma cells (5). Recent
studies have suggested that this protein is associated with the
cytoskeleton of these cells (6).
To explore the potential role ofPbo in Ca2'-mediatedinsulin
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release, we have directed the current studies toward identify-
ing the nature of this protein in greater detail. As there are
distinct differences between insulinoma cells and normal pan-
creatic beta-cells, it was also of importance to assess whether
P6o is a protein specific to insulinoma cells or whether it is
also expressed in normal islets.
The studies reported here demonstrate that Pso is a struc-
tural component of 10-nm filaments, which are generally
referred to as intermediate-sized filaments (for review, see
references 7 and 8). Based on electrophoretic and immuno-
logic properties of P6o, it was possible to assign insulinoma
cell intermediate filaments to the keratins, one of the five
intermediate filament classes currently distinguished (7, 8). In
addition, studies will be described that have shown, with the
help of a polyclonal antiserum specific for P60, this protein
to be present not only in insulinoma cellsbut also in normal
pancreatic islets and in the epithelium that shares a common
embryonic origin with islet cells.
1001MATERIALS AND METHODS
Materials:
￿
Na'25I (500 mCi/ml) was obtained from Amersham Corp.
(Arlington Heights, IL); Triton X-100, phenylmethanesulfonyl fluoride, and
DNase I were from SigmaChemical Co. (St. Louis, MO); urea from Schwarz/
Mann, (Orangeburg, NY); protein A from Pharmacia Inc., (Piscataway, NJ);
nitrocellulose sheets (0.45 km thick) from Schleicher and Schuell Inc., (Keene,
NH); Iodobeads (N-chloro-benzene sulfonamide-derivatized nonporous poly-
styrene beads) from PierceChemical Co. (Rockford, IL); and polyvinylchloride
microtitration plates from Dynatech Laboratories, Inc. (Alexandria, VA).
Preparation of Cytoskeletons:
￿
Hamster insulinomas were main-
tained by serial subcutaneous transplantation in female Syrian hamsters and
insulinoma cells isolated by collagenase digestion as previously described (9).
Cytoskeletons were prepared according to the procedure described by Franke
et al. (10) with slight modifications. Cells were lysed for 3 min at 0-4°C in cell
lysing buffer (140 mM NaCl, 1% Triton X-100 (vol/vol), 5 mM EDTA, 0.4
mM phenylmethanesulfonyl fluoride, 10 mM Tris-HCI, pH 7.6) and the nuclei
and cytoskeletons were collected by low speed centrifugation (3,000 g for 5
min). The pellet was then extracted at 0-4°C with 1.5 M KCl in cell lysing
buffer, to which DNase I and MgC12 were added to final concentrations of 1
mg/ml and 10 mM, respectively, to digest viscouschromatin material apparent
at this step. This required -10 min at 0-4°C. The cytoskeletons were then
pelleted as described above and reextracted with the same high salt buffer
(without the other additions) for 15 min at 0-4°C and washed twice with PBS.
The final pellets were stored at -20°C or used directly forthe studies described.
Electron Microscopy:
￿
Cytoskeletons resuspended in PBS were ap-
plied to carbon-coated electron microscope grids. After I min the preparations
were negatively stained with 2% uranyl acetate. The grids were examined in a
Siemens 101 electron microscope.
Two-dimensional Electrophoresis:
￿
Cytoskeleton pellets were dis-
solved in lysis buffer (11) and subjected to two-dimensional electrophoresis
according to the method ofO'Farrell (11) using minor modifications as previ-
ouslydescribed (6). The second dimension SDS polyacrylamide slab gels (8.5%
acrylamide) were either stained with Coomassie Blue as previously described
(4) or used for immunoblotting studies (see below).
Antibodies:
￿
The anti-P6o antibody was raised in a New Zealand rabbit.
P6o was obtained after two-dimensional electrophoresis by excising the corre-
sponding protein spots from multiple second dimension SDS polyacrylamide
slab gels stained with Coomassie Blue. The gel slices were minced with scissors
and liquified in a tightly fitting stainless steel Dounce homogenizer. The
resultant liquid was mixed in a plastic syringe with an equal volume ofcomplete
Freund's adjuvant and an emulsion was prepared by sonication. After preim-
mune serum was collected, the rabbit was injected at multiple intradermal and
subcutaneous dorsal sites with an estimated total amount of50-100 kg protein.
Subcutaneous booster injections ("25-50 Wg protein) were administered 1 and
2 mo later employing emulsionsofgel slices prepared as described aboveexcept
that incomplete Freund's adjuvant was used.
The rabbit was bled multiple times and the antibody titer was determined
by a solid-phase radioimmunoassay as described below. All studies reported
utilized serum from a single bleed.
Rabbit antivimentin antibody (12) was provided by Dr. Richard O. Hynes,
Massachusetts Institute of Technology, and a mouse monoclonal antibody
againstacommon antigenic determinant in intermediate filamentproteins (13)
by Dr. Rebecca M. Pruss, National Institutes of Health. A mixture of rat
monoclonal antibodies specific for mouse kappa and lambda light chains,
respectively, biosynthetically labeled with ["C]Arg and ["C]Lys (14) was a gift
from Dr. Matthew D. Scharff(Albert Einstein College of Medicine). Rhoda-
mine-labeled goat anti-rabbit immunoglobulin was from Miles Laboratories,
Inc. (Elkhart, IN).
Antibody Titration by Solid-phase Radioimmunoassay:
The titer of anti-P60 antibody was determined by a solid-phase radioimmu-
noassay similar to the one described by Pierce and Klinman (15). Polyvinyl-
chloride microtitration plates were coated at 0-4°C with 0.1-ml aliquots of
insulinoma cell cytoskeletons, which had been solubilized in 8 M urea, 25 mM
beta-mercaptoethanol, 10 mM Tris-HCI, pH 9.0, and diluted 50-fold to 50 kg/
ml with PBS. The wells were rinsed three times with PBS and loaded with
diluent (I% BSA, I % fetal calf serum, 10 mM sodium azide in PBS), which,
after 30 min at room temperature (RT),' was replaced by 0.1-ml aliquots of
immune serum serially diluted in diluent. After incubation for 1 h at 37°C,
rinsingwith PBS was repeated as above. Diluentcontaining "5I-labeled protein
A (5 x 104 cpm/0.1 ml) was then added to each well followed by incubation
for 30 min at 25°C. Afterthree additional washes with PBS, the amount of'251-
protein A bound to individual wells was determined in a gamma counter.
Background radioactivity was determined by using serial dilutions of preim-
'Abbreviation used in thispaper:
￿
RT, room temperature.
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mune serum. The anti-Pw antiserum used in the studiesdescribedbound, under
the conditions ofthisassay, 10% ofthe total radioactivityadded (approximately
three times background) at a dilution of 101.
Radioiodination of Protein A:
￿
For radioiodination of protein A,
50 g1 of 0.1 M sodium phosphate buffer, pH 7.0, one Iodobead, and 0.5 mCi
Na1251 (13-15 mCi/Ag iodine) were added to a plastic test tube. After preincu-
bation for 1 min at RT, 2 1I of protein A (5 mg/ml) was added. Following
incubation for 1 min at RT, the reaction was terminated by transferring the
reaction mixture toanother test tube leaving the Iodobead behind. Under these
conditions, 50-70% of the radioactivity was incorporated into trichloroacetic
acid-insoluble protein. The reaction mixture was diluted by addition of250 wl
of diluent (1% BSA, 1 % fetal calf serum, 10 mM sodium azide in PBS), and
applied to a 10-ml Sephadex G-25 column that had been prewashed with 10
ml ofdiluent and equilibrated with PBS. The column was eluted with PBS and
the fraction containing the initial peak ofradioactivity (>95% protein bound)
was mxied with diluent, aliquoted, and stored at -20°C for up to 3 wk without
appreciable loss in immunoglobulin binding activity.
Immunoblotting Methods:
￿
Immunoblotting was carried out ac-
cording to the method of Towbin et al. (16) with modifications. After two-
dimensional electrophoresis, the proteins were transferred to a nitrocellulose
sheet. Prior to electrophoresic transfer, the SDS polyacrylamide slab gel could
be stored in a closed container at -20°C for several weeks without effect on the
results obtained. After thawing, the gels were soaked briefly in 0.5% SDS.
Electrophoretic transfer was carried out for 4 h at 50 V in a Bio-Rad Transblot
apparatus (Bio-Rad Laboratories, Richmond, CA) filled with 25 mM Tris-192
mM glycine/methanol, 4:1 (vol/vol). The blot was stained briefly with amido
black and destained as described (16) and notched at the margins to mark the
position ofreference proteins. It could then be stored in 10 mM sodium azide
at 4°C for at least2 wk. Beforeincubation with antibody, the blot wasimmersed
in diluent (1% BSA, 1 % fetal calf serum, 10 mM sodium azide in PBS) and
incubated for 1 h at RT. The antibody to be tested was then directly added to
obtain the desired dilution. Incubation was continued first for 30-60 min at
RT with gentle shaking and then at 4°C overnight. The blot was then rinsed
twice for 10 min with 1 % (vol/vol) Triton X-100 in PBS and once with PBS.
Two methods were used fordetectingthe localization ofthe bound antibody.
For identification of rabbit immunoglobulin, 126I-protein A (5 x 105 cpm/ml
diluent) was used employing a 1-h incubation at RT. The mouse monoclonal
antibody (13) was localized using a "C-labeled rat monoclonal antibody (2.8
x 105 cpm/ml diluent) specific for mouse immunoglobulin light chains (14) in
an overnight incubation at 0-4°C. The blotswere then washed with mechanical
shaking in fourchanges of 1 % Triton X-100 (vol/vol) in PBS (each wash lasting
at least 20 min). After a brief rinse in PBS, the blots were dried between filter
papers and mounted on cardboard. The bound radioactive tracer was localized
by autoradiography using Kodax SB-5 X-ray film. Additional details are
provided in the legends to Fig. 2, 3, 5, and 8.
Immunofluorescence Microscopy:
￿
For indirect immunofluores-
cence microscopy, smears of freshly isolated cells (hamster insulinoma cells),
cells grown on glass coverslips (HeLa cells), or cryostat sections (10 jim) were
allowed to dry at RT for 1 h. They were then fixed for 30 s with 1 % acetic
acid/99% ethanol at -20°C and rinsed extensively with PBS. After a brief
application ofdiluent (I% BSA, I % fetal calfserum, 10 mM sodium azide in
PBS), the sections were covered with antiserum in diluent and incubated in a
moist chamber for 45 min at RT. After rinsing with PBS, diluent was again
applied briefly and replaced by rhodamine-labeled goat anti-rabbit immuno-
globulin diluted 1:300 in diluent. After 30 min at RT, the sections were rinsed
three times with PBS, fixedwith 5% acetic acid/95% ethanol for 30 s at -20°C,
and rinsed extensively with PBS. The slides were mounted in glycerol/PBS, 1:1
(vol/vol) and examined on a Zeiss standard microscope equipped with epiflu-
orescent UV illumination, selective filters for fluorescein or rhodamine, and
alternate phase-contrast illumination as previously described (17). For photog-
raphy, Kodak Tri-X film was used. For additional details see the legends to
Fig. 4, 6, and 7.
Pancreatic isletswereisolated from femaleSyrian hamsters usingthe method
ofLacy and Kostianovsky (18).
HeLa cells were obtained from Dr. Shu-Hui Yen (Albert Einstein College of
Medicine) and grown with Dulbecco's modified Eagle medium supplemented
with 10% fetal calfserum.
Protein was determined by a modification (19) of the method of Lowry et
al. (20) using BSA as standard.
RESULTS
Demonstration of the Presence of Intermediate
Filaments in Insulinoma Cell Cytoskeletons
Previous studies on the subzellular localization of Pbo have
demonstrated that the protein is highly enriched in a TritonX-100-insoluble cytoskeleton residue (6) . To identify the
structural elements present in such preparations, we examined
cytoskeletons by electron microscopy using negative staining.
As shown in Fig. 1, such preparations contain two apparent
size classes of filaments . The predominant structures are
unbranched filaments of nearly uniform diameter (7-11 nm).
Filaments ofthis appearance found in cytoskeletons ofmany
cells are generally referered to as intermediate-sized filaments
(7, 8). In addition, thinner filamentous elements (2-4 nm
diam) were noted (Fig. 1) . These may represent intermediate
filaments partially disassembled in the course of the prepara-
tion of cytoskeleton residues. Similar structures observed in
preparations of disassembled intermediate filaments from
various other sources have been referred to as protofilaments
(21-24).
These findings demonstratethat the predominant structural
elements ofinsulinoma cell cytoskeleton preparations closely
resemble intermediate filaments of other cell types. Since P6o
is one of the four major proteins that are present in these
preparations (see below), it is likely that it is a structural
component of intermediate filaments .
Immunologic Identification of Pbo as an
Insulinoma Cell Intermediate Filament Protein
The proteins present in the Triton X-100-insoluble cyto-
skeleton residue obtained from insulinoma cells were resolved
by two-dimensional electrophoresis and analyzed by immu-
noblotting . A representative gel stained with Coomassie Blue
is shown in Fig. 2 a . As demonstrated in previous studies, in
FIGURE 1 Ultrastructure of intermediate filaments isolated from
hamster insulinoma cells . Triton X-100-insoluble cytoskeletons
were prepared from freshly isolated insulinoma cells and negatively
stained as described in Materials and Methods . Bar, = 0.1 um .
x 120,000 .
FIGURE 2
￿
Immunoblot
analysis of insulinoma
cell cytoskeleton pro-
teins resolved by two-
dimensional electro-
phoresis . Aliquots (15
jug protein) of the same
cytoskeleton prepara-
tion were subjected to
two-dimensional elec-
trophoresis (11) and
either stained with
Coomassie Blue as
shown in a, or proc-
essed for immunoblot-
ting as shown in the au-
toradiograms depicted
in b-f. The antibodies
used and their respec-
tive dilutions were rab-
bit antivimentin (12),
1 :250 (b ; rabbit anti-P60
(see Materials and
Methods), 1 :25 (c) ;
1 :500 (d); and 1 :5000
(e); and mouse mono-
clonal anti-intermedi-
ate filament antibody
(13), 1 :250 (f) . The num-
bers at the left border
represent molecular
weight x 10-3 . Autora-
diographic exposure
was 6 h (c), 16 h (b, d,
and f), and 3 d (e), re-
spectively . The area of
the gel (a) or autoradiograms (b-f) shown contains all proteins
detected by staining or autoradiography, respectively .
which cytoskeletons obtained from "P-labeled cells were an-
alyzed by two-dimensional electrophoresis and peptide map-
ping (6), these preparations contain, in addition to P60 , three
other major proteins, all present in a partially phosphorylated
state. To illustrate this, the unphosphorylated form of Pbo,
molecular weight 60,000, isoelectric pH 6.0, is indicated by
the upward arrow (Fig. 2a, darker spot). The unphospho-
rylated forms of the other three proteins are indicated by
arrowheads . Their apparent molecular weight and isoelectric
pH are 59,000 and 6.3, 46,000 and 5.6, and 40,000 and 5.2,
respectively . The proteins migrating on the acidic side of all
four proteins are their phosphorylated derivatives (6) . A minor
protein also present in this preparation (oblique arrow, Fig.
2 a) was identified as vimentin as shown in the immunoblot
in Fig . 2b) . A gel run identically to the one depicted in Fig.
2 a was processed for immunoblotting using a vimentin-
specific antibody (12) . As evident in the corresponding auto-
radiogram (Fig . 26), the only protein spot recognized by the
antivimentin antibodywas this minor protein (oblique arrow) .
An antibody against Pbo was raised in a rabbit and its titer
was determined by a solid-phase radioimmunoassay (see Ma-
terials and Methods) . The specificity of this antibody was
assessed by immunoblotting using the same insulinoma cy-
toskeleton preparation. Fig . 2 shows the results obtained with
increasing dilutions ofthis antiserum . At lower dilutions (Fig.
2, c and d) some cross-reactivity was noted with the slightly
more basic protein migrating near Pbo . This cross-reactivity
probably resulted from the presence in the immune serum,
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a second antibody that was inadvertently raised against this
protein owing to the partial co-migration of the two proteins
on two-dimensional electrophoresis (Fig. 2 a, upward arrow) .
The additional minor spot (smaller andmore acidic than P6o)
also visible in Fig . 2, c and d, most likely represents a prote-
olytic fragment of P6o since it does not coincide with any of
the other proteins present in the preparation. At the highest
dilution utilized (1 :5000), the antiserum recognized only P6o
(upward arrow) and its phosphorylated derivatives (Fig . 2e) .
The anti-P 60 antiserum was also reacted with whole insuli-
noma cell proteins resolved by two-dimensional electropho-
resis. The resulting gel stained with Coomassie Blue and the
corresponding immunoblots are shown in Fig . 3 . At a low
dilution (1 :25, Fig. 3b), the antibody detected a few minor
spots in addition to P6o (upward arrow) and its more acidic
forms . At a dilution of 1 :100, P6o and its phosphorylated
derivatives were the only antigens identified by the antiserum
(Fig . 3 c) . The data demonstrate that this antiserum has a high
degree of specificity for P6o.
These studies have also utilized a monoclonal antibody that
is known to interact with an epitope common to all interme-
diate filament proteins (13) . As shown in Fig. 2f, this antibody
recognized all proteins present in this cytoskeleton prepara-
tion as detected by Coomassie Blue staining (Fig. 2a) . Al-
though it has not been unequivocally established that this
antibody interacts exclusivelywith intermediate filament pro-
teins, the data suggest that all proteins identified in the insu-
linoma cell cytoskeleton preparation may be subunits of
intermediate filaments .
As some cells have been shown to express vimentin in
addition to their cell type-specific intermediate filament pro-
tein(s) (for review, see references 7, 8, 25, and 26), the presence
of a small amount of vimentin in the insulinoma cell cyto-
skeletons suggested that these cells might represent another
example of co-expression of two intermediate filament types
within the same cell . To explore this possibility, we examined
insulinoma cells by indirect immunofluorescence microscopy.
Fig. 4 shows the results obtained with anti-P6o antiserum .
When the immunofluorescence (Fig . 4a) and corresponding
phase-contrast (Fig. 46) images are compared, it is evident
that the insulinoma cells yielded strong fluorescence in a
staining pattern reminiscent of intracellular filaments. No
staining was seen without prior permeabilization of the cells
(not shown) indicating that P6o is not expressed on the cell
surface . Slight background fluorescence was observed when
preimmune serum was used (Fig . 4c) . In contrast to the
findings obtained with the anti-P6o antibody, antivimentin
antibody produced a selective immunofluorescence staining
pattern . It bound to larger cells that accounted for <1% of
the total cell population but did not interact with the insuli-
noma cells (Fig. 4, e and f) . We conclude, therefore, that the
small amount of vimentin detected in the insulinoma cyto-
skeleton preparations is not present in these insulinoma cells
but in another cell type contaminating the cell preparation .
Because of their coarse granular inclusions, these cells were
tentatively identified as macrophages.
Presence of P6o in Normal Islet Cells and in the
Epithelium of Pancreatic Exocrine Ducts
Pancreatic islets obtained from hamster pancreas by colla-
genase digestion (18) were examined for the presence of P60-
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FIGURE 3
￿
Immunoblot analysis of whole insulinoma cell proteins
resolved by two-dimensional electrophoresis using anti-P6o anti-
body . Hamster insulinoma cells (150 tag protein) were directly
dissolved in lysis buffer (11) and analyzed as in Fig 2 . (a) Gel stained
with Coomassie Blue ; (b and c) immunoblots using anti-P6o antise-
rum diluted 1 :25 (b) and 1 :100 (c), respectively . Autoradiographic
exposure : b, 2 d ; c, 6 d . The numbers at the left border correspond
to the positions of standard proteins (BSA, glutamate dehydrogen-
ase, and carbonic anhydrase, respectively) applied adjacent to the
isoelectric focusing gelon theSDS slab gel and represent molecular
weight x 10-3.
The islet proteins were resolved by two-dimensional electro-
phoresis and stained with Coomassie Blue as shown in Fig .
5a. For reference, note the most prominent protein spot,
which is BSA carried over from the buffer used in the islet
isolation . An identical gel was processed for immunoblotting
and the corresponding autoradiogram is shown in Fig. 5 b.
The anti-P6o antibody interacted with a single group ofclosely
migrating islet proteins exhibiting a migration behavior on
two-dimensional electrophoresis identical to that of insuli-
noma cell P6o and its phosphorylated derivatives . The corre-FIGURE 4
￿
Indirect immunofluorescence microscopy on hamster insulinoma cells . Phase-contrast images are shown in the right
panels and the corresponding red fluorescence images in the left panels. The antisera used and their respective dilutions were
rabbit anti-P60 antibody ; 1 :50 (a and b) ; rabbit preimmune serum, 1 :50 (c and d) ; rabbit antivimentin antibody (12), 1 :100 (e and
0 . Fluorescence exposure, 10 s . x 900 .
sponding predominant protein spot on the gel is indicatedby
￿
examined cryostat sections of hamster pancreas by indirect
the arrow (Fig. 5 a) .
￿
immunofluorescence microscopy employing the anti-Pbo an-
To confirm the presence of P6o in pancreatic islets, we
￿
tiserum . Immunofluorescence staining of an islet is shown in
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￿
Demonstration of the presence of P60 in pancreatic islets
by immunoblotting . Microdissected hamster islets (75 islets) were
analyzed as in Fig. 3 . (a) Gel stained with Coomassie Blue; (b)
immunoblot using rabbit anti-Pw antiserum diluted 1 :100 . Autora-
diographic exposure, 2 d . (Numbers at left border, molecular weight
x 10-' .)
Fig . 6 a . This staining was specific, as it was not obtained with
preimmune serum (Fig . 6 c) . Some staining of exocrine
pancreatic tissue surrounding the islet was also observed (Fig.
6 a). At least in part, this was not due to specific antibody
binding inasmuch as similar staining was observed when
preimmune serum was used (Fig. 6c). Bright staining of the
epithelial layer of pancreatic exocrine ducts was also noted
(Fig . 6 b) and this staining was not reproduced by preimmune
serum (Fig. 6d) . Thus, the data suggest that P6o is not only
present in hamster insulinoma cells but also in normal pan-
creatic islets and in the epithelium of pancreatic exocrine
ducts .
Demonstration That Pbo Is Analogous to a
Keratin-type Intermediate Filament Protein
Present in HeLa Cells
The migration of P6o on two-dimensional electrophoresis
resembles that of a previously described keratin present in
HeLa cells and some other epithelial cells (10, 28-30) . To test
whether P6o is related to this keratin, we examined HeLa cells
by indirect immunofluorescence microscopy using the anti-
P60 antiserum . As shown in Fig . 7, the resultant fluorescence
staining pattern is characteristic of keratin-type intermediate
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filaments . This staining was not reproduced with preimmune
serum .
To examine which protein(s) in these filaments reacted with
the anti-P6o antibody, we prepared Triton X-100-insoluble
cytoskeletons from HeLa cells and analyzed them by two-
dimensional electrophoresis and immunoblotting (Fig . 8) .
The gel stained with Coomassie Blue (Fig. 8a) shows that
these preparations contain, in addition to vimentin (v,
bracket), three other proteins, which were previously identi-
fied as cytokeratins (10, 29, 30) . An additional minor keratin
described in earlier reports (10, 28-30) was not detected in
our preparation by staining with Coomassie Blue. The posi-
tions ofthe three keratins on the two-dimensional electropho-
resis gel resemble closely those of three ofthe insulinoma cell
intermediate filament proteins (compare Fig. 8a and Fig . 2 a) .
These are P6o (Fig. 8, arrow), and the two other insulinoma
cytoskeleton proteins, 59,000 and 46,000 mol wt, respectively
(Fig. 8a, arrowheads) . It appears that the latter protein over-
laps partially with residual actin, also present in the prepara-
tion.
For the immunoblots shown in Fig. 8, b and c, two different
dilutions of the anti-P6o antiserum were used. The antibody
reacted with two proteins that correspond to P6o and the
59,000-mol-wt insulinoma cell intermediate filament protein
migrating near P6o, respectively. These findings are analogous
to those obtained with insulinoma cell proteins (Figs. 2 and
3) . The anti-P6o antibody bound preferentially to the HeLa
cell keratin that shows a migration on two-dimensional elec-
trophoresis identical to that of P6o . The data suggest that P6o
is the hamster analog to this human keratin .
DISCUSSION
The present report describes the cytoskeletal nature of a
60,000-mol-wt insulinoma cell protein, P6o , which was previ-
ously shown to undergo calcium influx-stimulated phospho-
rylation in intact insulinoma cells, concomitant with insulin
release (5) . P6o was shown to be a structural component of
intermediate filaments using several criteria : (a) it was found
in Triton X-100-insoluble cytoskeletons, a cell residue rich
in intermediate filaments, as demonstrated previously in nu-
merous other studies (for review, see references 7 and 8); (b)
examination of insulinoma cell cytoskeletons by electron
microscopy identified intermediate-sized filaments (Fig. 1) ;
and (c) P6o and the other three proteins found in insulinoma
cell cytoskeletons were all recognized by a monoclonal anti-
body known to interact with an epitope shared by all inter-
mediate filament proteins (Fig . 2f ) (13) .
A small amount of vimentin, the intermediate filament
protein of fibroblasts and other mesenchymally derived cells
(7, 8), was also identified in insulinoma cell cytoskeleton
preparations . However, in contrast to certain other cells (e.g .,
some cultured cells, glial cells, and vascular smooth muscle
cells), which contain vimentin in addition to their cell type-
specific intermediate filament protein(s) (7, 8, 25, 26), vimen-
tin is not present in these insulinoma cells but resides in
contaminating cellstentatively identified as macrophages(Fig.
4, e andf ) .
In addition to insulinoma cells, P6o appears also to be
present in normal islets, as demonstrated by immunoblotting
(Fig. 5) and indirect immunofluorescence microscopy (Fig.
6) . With the aid of the rabbit anti-P6o antibody, the tissue
distribution ofP6o is currently being studied in this laboratory.
The protein appears not to be restricted to islet cells becauseFIGURE 6
￿
Demonstration of the presence of P60 in hamster pancreas by indirect immunofluorescence microscopy on cryostat
sections . The section shown in the upper panels (a and b) was stained with anti-P 60 antibody diluted 1 :50 ; the section in the
lower panels (c and d) with preimmune serum (1 :50 dilution) . Areas containing an islet (left panels) or an exocrine duct (right
panels), respectively, are shown . Fluorescence exposure : left panels, 2 min ; right panels, 30 s . x 530 .
the anti-P60antibody was able to detect an antigen in epithelial
cells of pancreatic exocrine ducts, which, however, has not
yet been shown to be structurally identical to Pbo. The present
studies also suggest that islet cells contain intermediate fila-
ments of the epithelial type, which are the most diverse of
five classes of intermediate filaments currently distinguished
(7, 8, 10, 25-27) . Based on their molecular weight and isoe-
lectric pH as determined by two-dimensional electrophoresis,
the four insulinoma cell intermediate filament proteins are
distinct from vimentin, desmin, glial fibrillary acidic protein,
and neurofilament proteins . In contrast, the insulinoma cell
proteins closely resemble certain intermediate filament pro-
teins of epithelial cells . This class of proteins has been exten-
sively studied in a number of laboratories and referred to as
prekeratins, keratins, keratin-like proteins, or cytokeratins(for
review, see references 7, 8, and 25-27) . A map of the two-
dimensional electrophoretic migration of 19 distinct human
cytokeratins that are found in various combinations charac-
teristic for different human epithelia was recently published
by Moll et al . (25). Indeed, the electrophoretic migration of
three of the insulinoma cell intermediate filament proteins
appears to be identical to three cytokeratins represented on
thismap . Thus, the proteins with molecularweights of59,000,
46,000, and 40,000 may be analogues of cytokeratins (8, 18,
and 19 respectively, according to the nomenclature of Moll
et al . (25). Studies are currently in progress to examine the
relationship of these proteins more closely by comparing the
peptide maps of the respective proteins ofepithelial cells and
ofinsulinoma cells.
Inasmuch as the migration of P6o on two-dimensional elec-
trophoresis suggested that this protein may be analogous to
cytokeratin 7 (25), the relationship of these two proteins was
examined with the aid of the anti-P60 antibody . Using HeLa
cells that are known to contain cytokeratin 7 (10, 28), we
have shown that the anti-No antibody, which has a high
degree of specificity, produces, on indirect immunofluores-
cence microscopy, a staining pattern characteristic of keratin-
type filaments (Fig . 7). In addition, it was demonstrated by
immunoblotting that anti-P60 antibody binds to cytokeratin 7
(Fig. 8) . The different estimates of the molecular weight of
this protein which are 54,000 (10), 50,000 (28), and 60,000
(this study), respectively, are likely the result of technical
differences . Thus, based not only on the identical migration
ofthe two proteins on two-dimensional electrophoresis (com-
pare Figs . 2a and 8 a) but also on their immunologic relat-
edness, the data suggest that Pso and cytokeratin 7 are analo-
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￿
Indirect immunofluorescence staining of HeLa cells us-
ing anti-P60. HeLa cells were grown on glass coverslips and proc-
essed for indirect immunofluorescence microscopy using anti-P60
antibody at dilutions of 1 :50 (a), and 1 :100 (b) . Fluorescence expo-
sure : (a) 1 min; (b) 2 min . X 880.
gous proteins . Taken together, the evidence presented in this
report suggests that islet cell intermediate filaments are of the
keratin type .
The composition of intermediate filament proteins in islet
cells has not been previously reported. It is now well estab-
lished that intermediate filament proteins are cell type-spe-
-ific and thus provide information regarding cellular origin
(7, 8, 25-27) . In this regard, the finding of keratins in pan-
creatic islets attests to their epithelial nature. Numerous his-
tologic studies have suggested that iselts are of endodermal
origin and are derived from the primitive pancreatic duct (for
review, see reference 31). In contrast, the demonstration that
islet cells have amine precursor uptake and decarboxylation
characteristics led Pierce to suggest that islets may be derived
from the neural crest (32) . This notion was further supported
by Schmechel et al. who provided evidence for the presence
of neural-specific enolase in islets (33) . However, develop-
mental studies have established conclusively that islets are not
of neural crest origin (for review, see reference 34) . Neverthe-
less, the cytologic properties that islet cells share with other
"neuroendocrine" cells remain an intriguing enigma of cyto-
differentiation. The findings in the present report are most
consistent with an endodermal origin of islet cells based on
the demonstration that islet cell intermediate filaments are of
the keratin type and that at least one of the islet cell keratins
(P6o) appears also to be expressed in the epithelium of pan-
creatic exocrine ducts .
The function of intermediate filaments is still poorly un-
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FIGURE 8 Immuno-
blot analysis of HeLa
cell intermediate fila-
ment proteins resolved
by two-dimensional
electrophoresis . Ali-
quots (15 Wg) of Triton
X-100-insoluble cyto-
skeleton proteins ob-
tained from HeLa cells
were analyzed as in Fig.
3. (a) Gel stained with
Coomassie Blue ; (b and
c) immunoblots using
anti-P60 antiserum di-
luted 1 :100 (b) and
1 :500 (c) . Autoradi-
ographic exposure, 2 d .
V, vimentin .
derstood. It is also not known if and how the properties of
intermediate filament proteins may be altered by phosphoryl-
ation, even though many ofthem have been shown to contain
phosphate (7, 8) . In the case of P60, this protein was shown
previously to undergo Ca"-dependent phosphorylation in
insulinoma cells (5, 6). Inasmuch as Ca" plays a critical role
in insulin release, the findings presented in this report suggest
the possibility that intermediate filaments may be involved in
the process of exocytosis in pancreatic beta cells. Although
such a role is speculative at present, further studies should
provide interesting insights regarding the possible interaction
ofthese cytoskeletal structures with elements of the secretory
apparatus .
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